Metropolitan Life Insurance CO Mirati Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

41 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$75.82 - $150.97 $186,593 - $371,537	-2,461 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$132.01 - $190.29 $324,876 - $468,303	2,461 New	2,461 $361,000
Q4 2021 Mar 30, 2023	BUY	$132.01 - $190.29 $35,246 - $50,807	267 Added 12.17%	2,461 $361,000
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $35,246 - $50,807	267 Added 12.17%	2,461 $361,000
Q3 2021 Jun 21, 2023	BUY	$132.13 - $177.45 $307,070 - $412,393	2,324 New	2,324 $411,000
Q3 2021 Mar 30, 2023	SELL	$132.13 - $177.45 $27,350 - $36,732	-207 Reduced 8.62%	2,194 $388,000
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $27,350 - $36,732	-207 Reduced 8.62%	2,194 $388,000
Q2 2021 Jun 21, 2023	BUY	$144.0 - $179.73 $345,744 - $431,531	2,401 New	2,401 $387,000
Q2 2021 Mar 30, 2023	SELL	$144.0 - $179.73 $1.29 Million - $1.61 Million	-8,946 Reduced 78.84%	2,401 $387,000
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $344,160 - $429,554	2,390 Added 21727.27%	2,401 $388,000
Q1 2021 Jun 26, 2023	BUY	$158.92 - $221.61 $1.8 Million - $2.51 Million	11,347 New	11,347 $1.94 Billion
Q1 2021 Mar 30, 2023	SELL	$158.92 - $221.61 $74,533 - $103,935	-469 Reduced 3.97%	11,347 $1.94 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $1.88 Million - $2.62 Million	-11,805 Reduced 99.91%	11 $1.94 Million
Q4 2020 Jun 22, 2023	BUY	$162.05 - $240.27 $1.91 Million - $2.84 Million	11,816 New	11,816 $2.6 Million
Q4 2020 Mar 30, 2023	BUY	$162.05 - $240.27 $176,472 - $261,654	1,089 Added 10.15%	11,816 $2.6 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $176,472 - $261,654	1,089 Added 10.15%	11,816 $2.6 Million
Q3 2020 Jun 26, 2023	BUY	$113.26 - $167.27 $1.21 Million - $1.79 Million	10,727 New	10,727 $1.78 Million
Q3 2020 Mar 30, 2023	SELL	$113.26 - $167.27 $50,174 - $74,100	-443 Reduced 3.97%	10,727 $1.78 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $50,174 - $74,100	-443 Reduced 3.97%	10,727 $1.78 Million
Q2 2020 Jun 26, 2023	BUY	$72.01 - $120.39 $804,351 - $1.34 Million	11,170 New	11,170 $1.28 Million
Q2 2020 Mar 30, 2023	BUY	$72.01 - $120.39 $160,006 - $267,506	2,222 Added 24.83%	11,170 $1.28 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $160,006 - $267,506	2,222 Added 24.83%	11,170 $1.28 Million
Q1 2020 Jul 12, 2023	BUY	$69.78 - $116.21 $624,391 - $1.04 Million	8,948 New	8,948 $687,000
Q1 2020 Mar 30, 2023	BUY	$69.78 - $116.21 $29,377 - $48,924	421 Added 4.94%	8,948 $687,000
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $29,377 - $48,924	421 Added 4.94%	8,948 $688,000
Q4 2019 Jul 12, 2023	BUY	$70.76 - $128.86 $603,370 - $1.1 Million	8,527 New	8,527 $1.1 Million
Q4 2019 Mar 30, 2023	SELL	$70.76 - $128.86 $12,666 - $23,065	-179 Reduced 2.06%	8,527 $1.1 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $12,666 - $23,065	-179 Reduced 2.06%	8,527 $1.1 Million
Q3 2019 Jul 12, 2023	BUY	$77.91 - $109.6 $678,284 - $954,177	8,706 New	8,706 $678,000
Q3 2019 Mar 30, 2023	BUY	$77.91 - $109.6 $143,042 - $201,225	1,836 Added 26.72%	8,706 $678,000
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $143,042 - $201,225	1,836 Added 26.72%	8,706 $678,000
Q2 2019 Jul 12, 2023	BUY	$59.49 - $104.71 $427,673 - $752,760	7,189 New	7,189 $740,000
Q1 2019 Jul 13, 2023	BUY	$43.65 - $78.95 $299,875 - $542,386	6,870 New	6,870 $503,000
Q1 2019 Mar 30, 2023	BUY	$43.65 - $78.95 $299,875 - $542,386	6,870 New	6,870 $503,000
Q1 2019 May 16, 2019	SELL	$43.65 - $78.95 $83,633 - $151,268	-1,916 Reduced 21.81%	6,870 $503,000
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $101,922 - $184,348	2,335 Added 36.2%	8,786 $1.2 Million
Q4 2018 Jul 13, 2023	BUY	$32.0 - $47.43 $206,432 - $305,970	6,451 New	6,451 $273,000
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $163,904 - $242,936	5,122 Added 385.4%	6,451 $274,000
Q3 2018 Jul 13, 2023	BUY	$47.1 - $62.7 $285,849 - $380,526	6,069 New	6,069 $286 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $223,254 - $297,198	-4,740 Reduced 78.1%	1,329 $63,000
Q2 2018 Aug 15, 2018	BUY	$26.05 - $52.4 $158,097 - $318,015	6,069 New	6,069 $0

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account